The Enterprise Value as of November 2024 (TTM) for Dynavax Technologies Corporation (DVAX) is 1.69B

According to Dynavax Technologies Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 1.69B. This represents a change of -7.33% compared to the average of 1.82B of the last 4 quarters.

Dynavax Technologies Corporation (DVAX) Historical Enterprise Value (quarterly & annually)

How has DVAX Enterprise Value performed in the past?

The mean historical Enterprise Value of Dynavax Technologies Corporation over the last ten years is 884.70M. The current 1.69B Enterprise Value has changed 18.98% with respect to the historical average. Over the past ten years (40 quarters), DVAX's Enterprise Value was at its highest in in the September 2021 quarter at 2.26B. The Enterprise Value was at its lowest in in the December 2016 quarter at 127.96M.

Dynavax Technologies Corporation (DVAX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dynavax Technologies Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dynavax Technologies Corporation (DVAX) Average Enterprise Value

How has DVAX Enterprise Value performed in the past?

The current Enterprise Value of Dynavax Technologies Corporation (DVAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Dynavax Technologies Corporation (DVAX) Enterprise Value vs. Peers

How is DVAX’s Enterprise Value compared to its peers?

Dynavax Technologies Corporation’s Enterprise Value is less than Alkermes plc (4.19B), less than Neurocrine Biosciences, Inc. (12.11B), less than Intra-Cellular Therapies, Inc. (8.69B), less than Deciphera Pharmaceuticals, Inc. (2.15B), greater than Aquestive Therapeutics, Inc. (427.93M), less than Amphastar Pharmaceuticals, Inc. (2.89B), less than Lantheus Holdings, Inc. (7.88B), greater than ANI Pharmaceuticals, Inc. (1.25B), greater than Ironwood Pharmaceuticals, Inc. (1.20B), greater than Pacira BioSciences, Inc. (1.16B), greater than Collegium Pharmaceutical, Inc. (1.44B), greater than Eagle Pharmaceuticals, Inc. (16.86M), greater than Emergent BioSolutions Inc. (1.28B), greater than DURECT Corporation (42.32M),

Build a custom stock screener for Dynavax Technologies Corporation (DVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dynavax Technologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dynavax Technologies Corporation (DVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dynavax Technologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.